Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Millennium and MorphoSys expand antibody development agreement

March 23, 2000

Potent, selective c-Src TK inhibitor identified using new target-based method

March 16, 2000

Medarex and Regeneron form human antibody drug collaboration

March 15, 2000

3-D and Boehringer Ingelheim enter R&D collaboration

March 15, 2000

Corixa, QLT team up to expand the possibilities of photodynamic therapy

March 10, 2000

Millennium gains broad access to XenoMouse technology

March 10, 2000

Patent broadens protection for Endorex's oral/mucosal drug delivery system

March 8, 2000

Immunomedics successfully delivers cancer drug through bispecific fusion proteins

March 8, 2000

Gelkem and Ethypharm to jointly develop controlled-release drugs

March 7, 2000

New use patents expand coverage for Aradigm's pulmonary drug delivery system

March 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...